News
Today’s announcement (August 20) on draft guidelines from the UK’s National Institute for Health and Care Excellence (NICE) ...
In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...
A Shropshire GP has said many patients are worried about having to stop their weight loss journey as the cost of Mounjaro is ...
Trump calls for API stockpile, OCOchem to scale up chemicals from carbon dioxide, Covestro to buy isocyanates plants, and ...
Ozempic price slashed following Donald Trump's demands - will it impact the UK cost? - Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump ...
Lilly to raise UK Mounjaro price 170% from £122 to £330 monthly amid White House push for European drug price increases to ...
Ozempic sales have risen five-fold after a 126 per cent rise in the price of the Mounjaro drug due to pressure from US ...
Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...
Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead
Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results